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Localisation of Protein Kinase A (PKA) by A-Kinase Anchoring Proteins (AKAPs) is known to coordinate localised signalling complexes that
target cAMP-mediated signalling to specific cellular sub-domains. The cAMP PKA signalling pathway is implicated in both meiotic arrest and
meiotic resumption, thus spatio-temporal changes in PKA localisation during development may determine the oocytes response to changes in
cAMP. In this study we aim to establish whether changes in PKA localisation occur during oocyte and early embryo development.
Using fluorescently-labelled PKA constructs we show that in meiotically incompetent oocytes PKA is distributed throughout the cytoplasm
and shows no punctuate localisation. As meiotic competence is acquired, PKA associates with mitochondria. Immature germinal vesicle (GV)
stage oocytes show an aggregation of PKA around the GV and PKA remains co-localised with mitochondria throughout oocyte maturation. After
fertilisation, the punctuate, mitochondrial distribution was lost, such that by the 2-cell stage there was no evidence of PKA localisation. RT-PCR
and Western blotting revealed two candidate AKAPs that are known to be targeted to mitochondria, AKAP1 and D-AKAP2. In summary these
data show a dynamic regulation of PKA localisation during oocyte and early embryo development.
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Mammalian oocytes are arrested in prophase of meiosis I.
Meiotic resumption is normally stimulated by a surge in the
gonadotrophins, luteinizing hormone (LH) and follicle stimu-
lating hormone (FSH) which are known to increase cAMP in
the somatic cells of the follicle. Alternatively, releasing the
oocyte from the follicular environment allows meiotic progres-
sion (Pincus and Enzmann, 1935; Edwards, 1965). Cyclic
adenosine 5′monophosphate (cAMP) is thought to play a major
role in controlling meiotic arrest. This was first demonstrated by
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doi:10.1016/j.ydbio.2008.01.045or phosphodiesterase (PDE) inhibitors, which elevate the cAMP
levels inside the oocyte, to maintain meiotic arrest in vitro
(Schultz et al., 1983; Conti et al., 1998; Tsafriri et al., 1996).
Much debate has centred on whether the oocyte regulates
and maintains high cAMP levels or whether the cAMP is
derived from the follicular somatic (granulosa) cells coupled to
the oocyte by gap-junctions. In support of the idea that the
oocyte controls cAMP levels, recent evidence has shown that
the oocyte produces cAMP via an orphan G-protein receptor,
GPR3. Ordinarily GPR3 elevates cAMP in the oocyte and as a
result, oocytes from GPR3 receptor−/− mice undergo sponta-
neous maturation within the follicle (Mehlmann et al., 2004;
Hinckley et al., 2005; Mehlmann, 2005a,b). Spontaneous
maturation of the oocyte is also observed when other signalling
molecules downstream of GPR3 are deleted, such as the cAMP
producing enzyme adenylyl cyclase III (Horner et al., 2003),
and also when an inhibitory antibody to Gs, the heterotrimeric
G-protein that activates adenylyl cyclase, is injected into the
intact follicle (Mehlmann et al., 2002, 2004).
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downstream of this receptor demonstrate the necessity for this
active pathway to maintain meiotic arrest. However since
oocytes undergo spontaneous maturation on release from the
follicle it can be presumed that a follicular contribution is
necessary to maintain the levels of cAMP in the oocyte. One
alternative source of cAMP is from gap-junctionally coupled
follicular cells. The addition of carbenoxolone (which blocks
gap junctions) to either isolated intact follicles, or administered
to mice by intrabusal injection, results in meiotic maturation
with a corresponding drop in the levels of cAMP within the
oocyte (Sela-Abramovich et al., 2006). This suggests a role for
somatic cell-derived cAMP in meiotic arrest and that during
meiotic arrest either cAMP or a molecule involved in
maintaining GPR3 activation requires gap junction commu-
nication. So, although a role for GPR3 is well established in
meiotic arrest a second contribution from the follicular somatic
cells also appears to be required.
This inhibitory role for cAMP in oocyte maturation is at odds
with the observation that maturation is stimulated by a mid-
cycle surge in the gonadotrophins, LH and FSH, both of which
stimulate cAMP production. It is not known precisely how
cAMP levels change within the oocyte following the hormonal
surge. We have previously described how cAMP generated in
response to FSH diffuses into the oocyte from the cumulus cells
via gap junctions (Webb et al., 2002). Furthermore, when the
oocyte itself is transiently exposed to a high level of cAMP or its
cell permeable analogues then maturation is permitted rather
than inhibited. For example oocytes can be arrested by exposure
to 200 μM dibutyryl cAMP yet a further increase to 1 mM
dibutyryl cAMP, induces meiotic resumption (Eppig and
Downs, 1987; Downs and Hunzicker, 1995); an effect also
seen when performed with intact isolated follicles (Dekel et al.,
1988; Dekel and Sherizly, 1983; Yoshimura et al., 1992).
These apparent paradoxical actions of cAMP might be
explained by the spatial localisation of the downstream
signalling proteins involved. The best characterised actions of
cAMP are via Protein Kinase A (PKA). PKA is a heterotetramer
consisting of 2 catalytic and 2 regulatory subunits. When cAMP
levels are high the catalytic subunits of PKA are released from
the holoenzyme allowing the phosphorylation of target mole-
cules such as the cyclic AMP response element binding (CREB)
protein and other proteins (Spaulding, 1993; Francis and Corbin,
1994; Montminy, 1997). Studies in cardiac cells have demon-
strated the localisation of PKA to the junctional sarcoplasmic
reticulum allows for small localised PKA responses. In these
cells the downstream actions of real-time changes in cAMPwere
shown to be highly localised when the physiological β-
adrenergic agonist was applied, but not when global activation
was induced with a phosphodiaesterase inhibitor (Zaccolo et al.,
2000, 2002; Zaccolo and Pozzan, 2002). A similar effect was
also observed in human embryoinic kidney cells which when
stimulated by PGE1 showed a transient rise in cAMP
concentration near the plasma membrane (Rich et al., 2001).
Localisation of PKA is mediated via the binding of the
regulatory subunit of PKA to a family of proteins known as A-
Kinase Anchoring Proteins, or AKAPs. AKAPs have beenfound in most tissues and contain an α-helical structural motif
which provides a binding site for the regulatory subunit of PKA,
thus anchoring the kinase to a specific subcellular localisation.
Despite the functional ability to bind the PKA regulatory
subunit, there is little sequence similarity within the AKAP
family. However most AKAPs contain identified regions for the
binding of other cellular proteins e.g. AKAP79 and AKAP250
(Gravin) which will also bind Protein Kinase C (Klauck et al.,
1996; Nauert et al., 1997; Smith et al., 2006). Hence AKAPs act
as molecular scaffolds nucleating signalling microdomains
within the cell.
Until recently, there was no evidence in oocytes to support
the localisation of PKA/cAMP signalling (Downs and Hun-
zicker, 1995). However over the past few years a number of
reports have suggested the presence of either a known AKAP,
such as the nuclear AKAP 7γ (Brown et al., 2003), or currently
unidentified PKA localising molecules (Brown et al., 2002;
Kovo et al., 2002; Webb et al., 2002). Both the localisation of
anti-RII antibodies and the fluorescent PKA protein FlCRhR,
showed a concentrated distribution around the Germinal Vesicle
(GV; nucleus) and a punctate distribution within the cytosol
(Brown et al., 2002; Kovo et al., 2002; Webb et al., 2002). These
data suggest the presence in oocytes of an AKAP that may
localise binding of the RII subunits, and this is supported by an
RII binding overlay assay which identified a 140 kDa protein as
a candidate AKAP (Brown et al., 2002: Kovo et al., 2002).
During the course of our study, Newhall et al. (2006) showed
that the 140 kDa protein is a product of the AKAP 1 gene.
Breeding studies in AKAP−/− mice resulted in a reduced litter
size, while in vitro stimulation of superovulation produces
degenerated or GV arrested oocytes with no polar bodies,
suggesting that AKAP 1 may be essential for meiotic maturation
and also for control of polar body extrusion.
In order to determine the sub-cellular localisation of PKA in
oocytes and its dynamic changes we have investigated further
the binding of exogenous PKA that we previously reported
using fluorescently labelled PKA; YFP-PKACat and CFP-PKA-
RegII (Zaccolo and Pozzan, 2002). We use this method to
illustrate changes in PKA localisation during oocyte growth,
maturation and early embryo development.
Materials and methods
Collection of oocytes from pre-antral follicles
MF1 mice between 12 and 18 days post partum were culled by cervical
dislocation. The ovaries were removed and placed in Leibovitz (L15) medium
with L-glutamine (Molecular Probes), 1% (w/v) BSA, 100 mIU/mL Penicillin
and 100 mg/mL Streptomycin (All from Sigma, Poole) at 37 °C. The ovaries
were treated with collagenase type I (1 mg/mL in L15; Sigma) and pipetted up
and down vigorously then left for 20 min. Oocytes were recovered as the
basement wall dissolved and other somatic cells were removed by repetitive
pipetting. The oocytes were then washed 3 times with fresh medium and
collected into L15 prior to mirco-injection. The diameter of the oocytes was
measured.
Collection of full grown oocytes
For experiments using GV and MI stage oocytes MF1 mice (11–15 g) were
administered with 7.5 IU pregnant mares' serum gonadotrophin (PMSG;
Fig. 1. The catalytic subunit of PKA is localised in GVoocytes. mRNA for the
YFP-PKACat subunit was microinjected into GV stage oocytes (held in a arrest
by IBMX) and left for 2 h to allow protein production. The oocytes were washed
out of IBMX just prior to confocal microscopy. The fluorescent catalytic subunit
was found in the perinuclear area with some punctate distribution within the
cytoplasm (n=4).
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and the oocytes were released by scraping the edge of the ovary with a 27-gauge
needle. Oocytes surrounded by cumulus cells were collected and the cells
removed by repeat pipetting through a narrow bore pipette. Oocytes were then
collected into L15 medium containing 200 μM IBMX (Sigma) to maintain
meiotic arrest for GV studies or left to undergo germinal vesicle breakdown
(GVDB) in those experiments for which MI oocytes were required.
Collection of MII eggs and embryos
MII oocytes were obtained from MF1 mice which 48–52 h after the PMSG
injection were given a second injection of 5 IU human chorionic gonadotrophin
(hCG; Intervet). MII eggs were collected from the oviduct 13–16 h later, the
cumulus masses were released into L-15 containing hyaluronidase (150 U/mL;
embryo tested grade, Sigma, Poole), collected and washed 3 times. In order to
generate zygotes and embryos following the hCG injection females were placed
with a single male of the same strain. The oviducts were recovered at 27–28 and
36–50 h post-hCG injection for the collection of 1-cell, 2-cell and 4-cell
embryos.
Microinjection
All cells were pressure injected with a micropipette and Narishige
manipulators mounted on an inverted Zeiss microscope. Pipettes were back-
filled with mRNA for YFP-linked catalytic subunit of PKA (YFP-PKACat) and
CFP-linked regulatory linked RII subunit of PKA (CFP-PKARegII). The CFP is
attached to the carboxy terminus of RII therefore this attachment does not
interfere with AKAP binding, which occurs via the dimerisation/docking
domain at the amino-terminus of RII (Zaccolo and Pozzan, 2002). The gametes
and embryos were placed in a drop of L15 media and covered with mineral oil
(to prevent evaporation) and then immobilised using a holding pipette. The
injection pipette was pushed through the zona pellucida until it contacted the
oocyte plasma membrane. A brief over compensation of negative capacitance
caused the pipette tip to penetrate the oocyte and a pressure injection system
(pico pump, WPI) was used to inject the mRNA's into the oocyte or embryo.
PKA-RII and mitochondrial localisation
After microinjection the oocytes or embryos were left for 2 h for protein to
be expressed. The YFP-catalytic subunit was examined using 488 nm laser. For
experiments where the mitochondria were to be examined the cells were bathed
in the mitochondrial dye tetra methylrhodamine ethyl ester (TMRE; 25 μM;
Molecular Probes). GV stage oocytes were kept in media containing IBMX
(200 μM), to maintain meiotic arrest, and washed 3 times in IMBX free media
just prior to imaging. Initial experiments were carried out using a LSM 510 meta
confocal microscope to obtain an emission fingerprint for YFP- and TMRE
separately. These emission spectra or fingerprints were then used to separate the
2 signals when both indicators were present. The mRNA-injected oocytes were
washed free of IBMX prior to imaging and placed in a heated chamber with a
coverslip base on the stage of a Zeiss 100TV microscope. Emissions were
recorded and analysed using MetaMorph software.
RT-PCR
Oocytes and embryos were collected in groups of 100 and snap frozen in
liquid nitrogen, total RNAwas extracted using an RNeasy kit (Qiagen). cDNA
was synthesised using a ‘Reverse-IT’ kit (ABgene), using anchored oligo-dt
primers and adding b1 μg of total RNA per 20 μl reaction. Intron-spanning PCR
primers were designed, with reference to known mouse sequences and were
obtained from Sigma, sequences were as follows; GAPDH forward 5′ AAC
TTT GGC ATT GTG GAA GG 3′, GAPDH reverse 5′ ACA CAT TGG GGG
TAG GAA CA 3′, AKAP1 forward 5′ AAG CTATGA CCC CAC CAC TG 3′
AKAP1 reverse 5′ CGC AAC AGC TAT CCA CTG AA 3′, D-AKAP2 forward
5′ GGA GAA GAT GGA CAG GTG GA 3′, D-AKAP2 reverse 5′ GGG CTG
ACT CAC AGA AGA GG 3′, AKAPγ7 forward 5′ AAG AGG AAG TGG
CAC GAG AA 3′, AKAPγ7 reverse 5′ TGC TTC TCT TTG GGT TTG CT 3′.
The final composition of each 10 μl PCR reaction was: 0.5 μl cDNA(concentrations varied), 1 μM of each primer, 0.2 mM dNTPs, 0.25 units
‘HotStar’ Taq polymerase and 1× ‘HotStar’ PCR buffer (Qiagen). PCRs were
conducted using the following thermocycling conditions: 94 °C/15 min, 35
cycles of 94 °C/45 s, 65 °C/30 s (−0.3 °C per cycle), 72 °C/1 min, final
extension step of 72 °C/5 min. Products were analysed by running on 2%
Agarose gel, containing 1× GelRed (Biotium), and visualised under UV light.
To achieve semi-quantitative results loading volumes were adjusted to give
roughly equal band intensity with respect to the GAP-DH products for each
sample.
Western blotting
Samples of eggs at different developmental stages were prepared in SDS-
PAGE sample buffer and either used immediately or stored frozen. Proteins
were displayed on SDS-polyacrylamide 4–12% (w/v) gradient gels and then
transferred to a PVDF membrane. After blocking with milk proteins the
membranes were probed with specific antibodies and revealed with either anti-
mouse-HRP (BioRad) or anti-rabbit-HRP (Biorad) conjugates and ECL
(Piece).Results
YFP-PKACat is localised in mouse oocytes
We have previously found that micro-injected fluorescent
PKA, FlCRhR, is distributed around the GV and throughout
the cytoplasm in a punctate manner (Webb et al., 2002). To
reveal the distribution of the endogenous PKA regulatory
subunits, we microinjected mRNA encoding for the YFP-
PKACat subunit. In GV oocytes the catalytic subunit showed a
perinuclear localisation with punctate distribution in the
cytoplasm. The YFP-PKACat was excluded from the nucleus
in all cases (Fig. 1; n=4). This distribution was similar to that
previously seen with FlCRhR (Webb et al., 2002) and with RII
subunit antibodies (Brown et al., 2002; Kovo et al., 2002). The
punctuate distribution of the PKACat subunit suggests that, in
the absence of IBMX, endogenous cAMP levels in isolated
oocytes are not sufficient to cause the dissociation of PKA. A
low resting level of cAMP is supported by our previous
demonstration that isolated GV stage oocytes can be
stimulated to generate a significant increase in cAMP (Webb
et al., 2002).
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Next, we set out to determine the intracellular structure(s)
responsible for localising PKA. It is known that both the
mitochondria and the endoplasmic reticulum are found around
the GVand throughout the cytoplasm of GV stage oocytes. The
distribution of mitochondria in oocytes was monitored with
TMRE (25 μM) which localises to these organelles because of
their high membrane potential. To co-localise mitochondria and
PKA, oocytes that had been previously injected with YFP-
PKACat and CFP-PKARegII were loaded with TMRE and
examined using a confocal microscope. The results show that
mitochondria and PKA are co-localised in the cytoplasm of the
GV stage oocyte (Fig. 2; n=9). To determine whether
mitochondrial localisation of PKA persists during oocyte
maturation similar experiments were performed in oocytes
after GVBD (3–4 h after release from the follicle; Fig. 2b n=8)
and in mature ovulated oocytes (Fig. 2c; n=9). These studies
confirmed that mitochondria undergo redistribution as pre-
viously described (Tokura et al., 1993; Van Blerkom et al.,
2002), and that PKA remains co-localised at all stages
examined. Together these observations show that PKA is
localised to the mitochondria and that this association is
preserved during oocyte maturation from prophase I toFig. 2. Co-localisation of PKA-catalytic subunit and mitochondria in oocytes at dif
TMRE (25 μM) to label the mitochondria prior to confocal microscopy. The mitocho
shows the merged image where yellow reveals PKA and mitochondrial co-localisati
perinuclear area with some discrete spots in the cytoplasm (n=9). After GVBD (B) th
oocytes (C) the mitochondria and PKA are punctate throughout the cytoplasm and ametaphase II. Control observations were made with non-
injected oocytes and by injecting mRNA coding only for YFP
and these showed low levels of auto-fluorescence and a
homogeneous distribution respectively (data not shown).
To test whether mitochondria-bound PKAwas responsive to
increases in cAMP we applied IBMX (200 μM) to TMRE-
loaded MI stage oocytes, that had previously been injected with
YFP-PKACat. The sequence of images shown in Fig. 3
demonstrates that the IBMX-induced increases in cAMP
resulted in a redistribution of YFP-PKACat from the mitochon-
dria to the cytosol. There was no change in mitochondrial
distribution during this experiment showing that the loss of
fluorescence was due to movement of YFP-PKACat rather than
the mitochondria (n=3).
Localisation develops during the final stages of oocyte growth
To determine whether PKA is localised prior to oocyte
maturation we examined the distribution of YFP-PKACat in
oocytes isolated from pre-antral follicles. When oocytes from
pre-antral follicles expressing the PKA reporter construct were
analysed, there was no evidence for localisation of PKACat to
the mitochondria. PKA was dispersed homogeneously
throughout the cytosol and excluded from the nucleus. Aferent stages of maturation. Oocytes expressing YFP-PKACat were loaded with
ndria are shown in red, the catalytic subunit of PKA in green and the final panel
on. In GV stage oocytes (A) both the mitochondria and the PKA localise in the
e mitochondria and PKA are found around the spindle area (n=11). In MII stage
ppear excluded from the area of the MII plate (n=9).
Fig. 3. Redistribution of the catalytic subunit of PKA following an increase in
cAMP. Oocytes injected with YFP-PKACat were allowed to undergo GVBD and
were then loaded with TMRE (25 μM) and imaged as described in Materials and
methods. The arrow shows the addition of IBMX (200 μM) to increase cAMP.
The images are acquired at 10 s intervals and are shown successively from left to
right in descending rows as time evolves. (A) In low cAMP localisation of the
catalytic subunit of PKA is apparent, once cAMP is increased PKA became
homogeneously dispersed throughout the cell. The mitochondria (B) are
unaffected by the increase in cAMP. These images are representative of 3
separate experiments.
Fig. 4. PKA is not localised in oocytes from pre-antral follicles. Distribution of
PKA and mitochondria were imaged as described in Materials and methods. The
mitochondria (A) seen in punctate spots in the cytoplasm are shown in red. The
catalytic subunit of PKA (B, green) does not appear to be localised at the earlier
stage of development as demonstrated by the lack of yellow in the merged image
(C). D, shows the change in FRET between fluorescent catalytic and regulatory
subunits of PKA in oocytes, indicating and increase in intracellular cAMP
concentration.
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intact pre-antral follicles showing that the loss of localisation
was not caused by removal of the oocyte from the follicle
(n=10; Fig. 4).
The lack of localisation of the catalytic subunit in growing
oocytes may be due to developmental changes in the expression
of an AKAP or in the ability of the AKAP to bind PKA.
Alternatively, it may be the result of an elevated level of cAMP
in the oocyte leading to the dissociation of the catalytic subunit
(Fig. 4; n=8). To distinguish between these possibilities we
tested whether an increase in cAMP could be detected in
growing oocytes. Fluorescent PKAwas introduced into oocytes
in intact pre-antral follicles and the effect of increasing cAMP
was examined by monitoring the FRET interactions between the
catalytic and regulatory subunit during exposure to IBMX. The
addition of IBMX (200 μM) resulted in an increase of 0.22±
0.02 ratio units (n=8), consistent with the maximum cAMP-
inducible change in FRET that we reported previously in GV
stage oocytes (0.22±0.02; Webb et al., 2002). This indicates
that cAMP levels are similar to those seen in fully grownoocytes, and as such, an elevated level of cAMP is unlikely to
explain the lack of PKA localisation.
To determine at which stage during oocyte growth the
localisation begins to develop, we expressed PKA subunits in
oocytes from mice at 14, 16 and 18 days post partum: the period
over which oocytes acquire meiotic competence. At day 14 the
average oocyte diameter was 61.0±5.0 μm (n=158), and none
of the oocytes underwent GVBD (n=158). Localisation of
fluorescent PKA was not observed in any of the oocytes
examined (n=9; Fig. 5). At day 16 the mean diameter had
increased to 63.3±4.9 μm (n=160) and 26.0±13.0% (n=125)
of oocytes underwent GVBD. Localisation of PKAwas evident
in all of the oocytes (n=11; Fig. 5), although the intensity of
localisation was reduced compared to fully grown GV stage
oocytes. At day 18 the average diameter had increased to 68.8±
5.1 μm (n=333) and 34.1±2.2% (n=197) of oocytes under-
went spontaneous maturation. Similar to oocytes from 16-day-
old mice, PKA localisation was evident in all oocytes examined
(n=10). This is in comparison to fully grown oocytes from
PMSG injected mice where localisation was present in all
oocytes which had a diameter between 72 and 76 μm and in our
laboratory averaged 90% maturation (Webb et al., 2002).
PKA localisation is lost after fertilisation
The late onset of PKA localisation suggests a role in oocyte
maturation, early development or both. To determine whether
PKA remained localised to the mitochondria after fertilisation
Fig. 5. Localisation of PKA develops during oocyte growth. Distribution of PKA and mitochondria were imaged as in Materials and methods. Oocytes were either still
contained within a pre-antral follicle or isolated. An oocyte (A) within the follicle from a 12-day-old mouse shows no localisation of PKA. An isolated oocyte obtained
from a 14-day-old mouse also showed no localisation PKA. However, localisation can be observed from day 16 (C) and 18 (D) post partum.
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CFP-PKARegII; only one blastomere of the 2-cell embryo was
injected while 2 blastomeres were microinjected in the 4-cell
embryo. Hence not all the blastomeres expressed the PKAFig. 6. PKA localisation is lost following fertilisation. In vivo fertilised mouse em
mitochondria prior to confocal microscopy. In 1-cell embryos (A) the mitochondria ap
of co-localisation with the mitochondria (n=7). In both 2-cell (B) and 4-cell (C) emconstruct. TMRE, which reveals the mitochondrial distribu-
tion, was loaded into all blastomeres. These experiments
revealed a dramatic loss of localisation such that even by the
1-cell stage there was little evidence of PKA localisation to thebryos expressing YFP-PKACat were loaded with TMRE (25 μM) to label the
pears to be dispersed throughout the cytoplasm and PKA shows a small amount
bryos there is no localisation of PKA (n=6 and 3 respectively).
42 R.J. Webb et al. / Developmental Biology 317 (2008) 36–45mitochondria. No embryos examined after the 1-cell stage
showed any evidence of PKA localisation (Fig. 6; n=3–10).
AKAP mRNA and protein are both present in mouse oocytes
The localisation of PKA is mediated via the interaction of the
regulatory subunit of PKA with AKAPs. There are 2 AKAPs
known to localise to mitochondria. Firstly an AKAP identified
in sperm S-AKAP 84 (Lin et al., 1995; which has several splice
variants called AKAP 121 and AKAP 149 (also known as D-
AKAP1); Feliciello et al., 1998; Trendelenburg et al., 1996),
and D-AKAP2 (or AKAP 10: Huang et al., 1997; Wang et al.,
2001). Furthermore the presence of another AKAP, AKAPγ7
has been described in GVoocytes (Brown et al., 2003) and MII
oocytes (Newhall et al., 2006). Following normalisation for
signal abundance against the house-keeping gene GAP-DH,
both AKAP1 and D-AKAP2 show low levels of expression in
growing oocytes (Fig. 7a). The abundance of mRNA for both
AKAP1 and D-AKAP2 increases in the GV stage, peaks during
metaphase II and subsequently decreases in the 2-cell embryos.
AKAPγ7 expression follows a different pattern with respect to
oocyte maturation. In growing oocytes, GV stage and MII stage
expression remained constant. However the transcription level
of AKAPγ7 does appear to drop in the 2-cell embryo.Fig. 7. mRNA and protein are present for AKAP1 and D-AKAP2. Semi-
quantitative RT-PCR showing changing levels of messenger RNA expression
for AKAP1, D-AKAP2 and AKAPγ7 relative to GAPDH; in growing oocytes
(D12), GV stage eggs (GV), MII stage eggs (MII) and 2 cell embryos (2).
Western blotting (B) shows the reaction of anti-AKAP1 mAb (1:500; BDH)
against GV oocytes (650 oocytes) demonstrating the presence of the S-84
isoform of AKAP1. C shows rabbit polyclonal D-AKAP2 (1:500) against GV
oocytes (40 oocytes).The presence of the corresponding protein product was
confirmed in GV stage oocytes by Western blotting with
specific antibodies. The anti-AKAP1 antibody recognised a
single protein band at 84 kDa similar to that seen in sperm
suggesting the oocyte and sperm express the same iosform. The
anti-D-AKAP2 antibody recognised a major band at approxi-
mately 64 kDa and minor bands around 100 kDa and 59 kDa
(Fig. 7b; n=3).
Discussion
cAMP has a critical role in the control of meiotic resumption.
Here we show that in living mouse oocytes there is a
developmentally acquired localisation of PKA to the mitochon-
dria. This suggests a need for the spatial organisation of specific
signalling molecules, including PKA, during meiotic arrest,
meiotic maturation or both. The localisation of PKA is acquired
as the oocyte grows from 61 μM to 68 μM diameter. This
localisation persists throughout oocyte maturation and is no
longer detectable after fertilisation. RT-PCR showed changes in
AKAP 1 and D-AKAP2 mRNA levels during the oocytes
growth phase and fertilisation. mRNA levels were markedly
reduced in growing oocytes and 2 cell embryos suggesting the
loss of localisation is associated with low levels of expression.
Previously pharmacological studies had suggested that RI
subunit was the only isoform of PKA present in mammalian
oocytes (Downs and Hunzicker, 1995). However, subsequent
studies using antibodies and RII overlay assays revealed that
RII subunit is present in mouse and rat oocytes (Brown et al.,
2002; Kovo et al., 2002). Their data revealed similar sub-
cellular localisation of anti PKA-RII to that seen in our studies
with the PKA fluorescent protein FlCRhR (Webb et al., 2002)
and the exogenously expressed catalytic subunit (present study).
This punctuate peri-nuclear distribution of the catalytic subunit
of PKA in isolated GV stage oocytes is in contrast to earlier
immunofluorescence studies in rat oocytes which suggested the
catalytic subunit of PKA is localised to RI subunit at the plasma
membrane (Brown et al., 2002). The explanation for these
discrepancies is unclear but may relate to the different
techniques, species and different antibodies used to visualise
PKA.
Following GVBD, PKA redistributed throughout the
cytoplasm and was excluded from the spindle area but remained
localised to the mitochondria. Consistent with our studies those
of Brown et al. (2002) and Kovo et al. (2002) also show a
punctuate distribution of PKA that persists throughout matura-
tion in a pattern similar to the mitochondrial distribution in
mouse oocytes (Van Blerkom et al., 2002). The mitochondrial
localisation of PKA throughout maturation is not in agreement
with one study which suggests that the localisation of RII does
not take place until after oocyte maturation has been initiated
(Newhall et al., 2006). Further work is necessary to explain the
difference between these studies.
PKAwas found not to be localised in oocytes from pre-antral
follicles. Using follicles from 16–18-day-old mice our data
establishes that the localisation of PKA in oocytes occurs as the
oocyte grows and acquires meiotic competence. A recent study
43R.J. Webb et al. / Developmental Biology 317 (2008) 36–45in immature (growing) rat oocytes showed a switch in PKA
regulatory subunit isoform from RI, which is thought to be
generally cytosolic, to RII, which is known to be more localised,
as the oocyte becomes fully grown (Kovo et al., 2006).
Furthermore, when we looked at the localisation following in
vivo fertilisation, a small amount of protein was bound to the
same region as the mitochondria in the 1-cell embryo but this
was lost by the 2-cell stage. This lends support to the hypothesis
that PKA signalling localises, as the prophase 1 arrested oocyte
grows, in order to provide a signalling microdomain necessary
for meiotic arrest or maturation and that this characteristic
distribution is no longer required after fertilisation.
The lack of mitochondrial localisation of PKA in growing
oocytes and early embryos does not appear to be explained by
an elevated level of cAMP at these stages. We have previously
shown in fully-grown GV stage oocytes that the catalytic
subunit of PKA will redistribute and become homogeneously
located throughout the cytoplasm and the GV (nucleus) when
the cAMP concentration is increased in response to IBMX
(Webb et al., 2002). Here we extended this work to reveal a
similar PKA redistribution in growing oocytes in pre-antral
follicles, with the change in indicator ratio being equivalent to
the maximal change previously observed with cAMP indicators
(Adams et al., 1993; Goaillard et al., 2001; Stricker and Smythe,
2001; Webb et al., 2002; Zaccolo and Pozzan, 2002). This result
strongly suggests that when removed from the follicle the
cAMP level in growing oocytes is not elevated and therefore is
unlikely to explain the lack of PKA localisation. A further
indication that cAMP levels are low is suggested by the absence
of PKA-YFPCat from the GV. A number of other studies with
fluorescent cAMP indicators have shown that an increase in
cAMP results in the catalytic subunit entering the nucleus
(Harootunian et al., 1993; Webb et al., 2002; Zaccolo et al.,
2000). Although cAMP was not stimulated in embryos post
fertilisation, it is clearly seen that the YFP-PKACat is excluded
from the nucleus of all the embryos examined and this suggests
that cAMP levels are low in these conditions. Together this is
strong evidence that the changes in localisation of fluorescence
are a result of changes in the distribution of PKA and not
changes in the levels of cAMP.
The precise nature of the mechanisms underlying the
localisation of PKA during oocyte growth and those controlling
the changes in PKA binding are not known at present. One
possibility is the production of AKAP's as the oocyte grows and
becomes meiotically competent. Alternatively a change in
phosphorylation state of either the AKAP or the RII subunit
could provide a mechanism of controlling localisation. There is
evidence that phosphorylation of a 140 kDa protein occurs
during meiotic maturation as the oocyte undergoes GVBD
(Brown et al., 2002; Kovo et al., 2002). Furthermore AKAP1
(AKAP149) has been shown to bind the kinase PKC as well as
PKA and the phosphatase PP1, during G phase of the cell cycle.
However as the cell progresses to G1/S, phosphorylation leads
to the dissociation of PP1 which has been demonstrated to be
important for nuclear envelope assembly (Steen et al., 2003).
A number of anchoring proteins including AKAP1, and D-
AKAP2 are recognised to bind to the mitochondria (Huang etal., 1997; Feliciello et al., 1998; Trendelenburg et al., 1996). We
show that fully grown GV stage oocytes express mRNA and
protein for two mitochondrial AKAPs: AKAP1 and D-AKAP2.
Furthermore RT-PCR has demonstrated the presence of mRNA
for another AKAP, AKAPγ7 which has been reported to be
present in the nucleus in the GV stage oocyte (Brown et al.,
2003) and the cell membrane of AKAP1−/− mice (Newhall et
al., 2006). Semi-quantitative RT-PCR suggested that levels of
mRNA for both D-AKAP2 and AKAP1 were lower in growing
oocytes, increased in the GVand MII stage and decreased again
in the 2-cell embryos— a pattern consistent with that observed
with the exogenous PKA localisation.
A 140 kDa candidate PKA localising protein was observed
in both mouse (Brown et al., 2002) and rat (Kovo et al., 2002)
oocytes and this was recently shown to be the product of the
AKAP 1 gene (Newhall et al., 2006). Using a different antibody
we detect the S84 splice variant of AKAP1, which is also
observed in the study of Newhall et al. (2006). In the AKAP1−/−
mice both the 140 kDa and S84 kDa splice variants were
eliminated (Newhall et al., 2006: McKnight, personal commu-
nication), demonstrating that they are both products of the same
AKAP 1 gene.
Using an RII subunit overlay assay Newhall et al. (2006)
identified a number of PKA binding proteins in extracts of GV
stage oocytes. Amongst these proteins the most abundant was a
species of approximately 64 kDa. Using an anti D-AKAP2
antibody we detected a protein of a similar size along with a
further 2 proteins at approximately 98 and 59 kDa. Given the
number of RII binding proteins identified in the study of
Newhall et al., it is surprising that they find no evidence of RII
localisation at the GV stage as reported by others and the
reasons for these differences remain unclear. Nevertheless our
data demonstrates the presence of forms of AKAP1 and D-
AKAP2 variants in mouse oocytes.
As the localisation of PKA appears to be most prominent
during oocyte maturation this indicates that localised PKA
signalling may be important during either meiotic arrest or
maturation. In growing rat oocytes the PKA inhibitors H89 and
PKI both stimulated GVBD (Kovo et al., 2006), demonstrating
the role of PKA in maintaining meiotic arrest. However,
disruption of PKA localisation using the peptide inhibitor Ht31
causes an increase in GVBD in mouse oocytes (Newhall et al.,
2006) suggesting that localisation of the PKA signal is essential
in maintaining meiotic arrest. In contrast, oocytes from
AKAP1−/− mice appear to have delayed maturation when
stimulated in vivo suggesting that another AKAP, possibly D-
AKAP2, is responsible for mediating the stimulatory effects of
Ht31 peptide thus indicating that this AKAP plays a major
physiological role in maintaining meiotic arrest.
This report provides the first demonstration of develop-
mental changes in the localisation of PKA from the meiotically
incompetent oocyte through to early embryo development. We
have also identified a second AKAP, D-AKAP2 that is targeted
to mitochondria in mouse oocytes. We suggest that this protein
may be important for PKA mediated meiotic arrest, as this
spatial signal localised to the mitochondria appears during
oocyte growth and persists throughout maturation.
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